抗体-药物结合物（ADC）由理想的单克隆抗体、活性细胞毒性药物和合适的连接剂组成。抗体和细胞毒性药物之间的适当连接物提供特异性桥，从而帮助抗体选择性地将细胞毒性药物递送至肿瘤细胞，并在肿瘤部位精确地释放细胞毒性药物
tert-Butyl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oate
1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxapentadecan-15-oic acid
tert-Butyl 1-amino-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate
1-Phenyl-2,5,8,11,14,17,20-heptaoxadocosan-22-amine
4,7,10,13,16,19,22-Heptaoxapentacosane-1,25-dioic acid
17-(Boc-amino)-3,6,9,12,15-pentaoxa-1-heptadecanol
4,7,10,13,16,19,22,25,28-Nonaoxahentriaconta-1,30-diyne
tert-Butyl 1-bromo-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate
tert-Butyl 17-hydroxy-3,6,9,12,15-pentaoxaheptadecan-1-oate
1-Phenyl-2,5,8,11,14-pentaoxahexadecan-16-yl methanesulfonate
14-Amino-3,6,9,12-tetraoxatetradecan-1-oic acid
tert-Butyl 1-hydroxy-3,6,9,12,15,18-hexaoxahenicosan-21-oate
3,6,9,12,15,18,21,24,27,30,33-Undecaoxapentatriacontane-1,35-diamine
tert-Butyl 1-hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxatritriacontan-33-oate
3,6,9,12-Tetraoxapentadec-14-yn-1-yl methanesulfonate
4,7,10,13,16,19,22,25,28-Nonaoxahentriacontane-1,31-dioic acid
1-Mercapto-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid
tert-Butyl 1-bromo-3,6,9,12-tetraoxapentadecan-15-oate
2-(2-(2-Hydroxyethoxy)ethoxy)ethyl methanesulfonate
2-(2-(2-(2-((Tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethoxy)ethoxy)ethyl methanesulfonate
2-((1-Phenyl-2,5,8,11,14,17,20,23-octaoxapentacosan-25-yl)oxy)tetrahydro-2H-pyran
tert-Butyl 5,8,11,14-tetraoxa-2-azaheptadecan-17-oate
2-((1-Phenyl-2,5,8,11,14-pentaoxahexadecan-16-yl)oxy)tetrahydro-2H-pyran
4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate
2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-ol
2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azatricosan-23-oic acid
(14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-methyl-N-(3-(methyldisulfaneyl)propanoyl)-L-alaninate
(14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-Chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(4-mercapto-4-methylpentanoyl)-N-methyl-L-alaninate
MC-Val-Cit-PAB-MMAF
2,5,8,11-Tetraoxatridecan-13-yl 4-methylbenzenesulfonate
